Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 11/02/2025 8:37:06 AM
Board Marks: 394
Posts Today: 1
Board Views Today: 17284
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
Mr3Putt
07/09/2025 7:51:47 AM
Youve got to ask yourself one
(5)
chazzledazzle
07/08/2025 11:38:42 PM
I feel you. But Im strong. And a
(7)
cardamine
07/08/2025 11:19:50 PM
thanks, brentie -- LL's the only CCR5
(2)
mountaineer
07/08/2025 5:50:34 PM
Yes the following is AI generated, but
(8)
brentie
07/08/2025 4:16:26 PM
"Finally, the Leronlimab, Ulocuplumab,
(24)
Camp2800
07/08/2025 12:28:00 PM
When you add up all of the tea leaves
(11)
Riztheinvestor
07/08/2025 10:25:20 AM
When the FDA completely lost oversight
(7)
grow
07/08/2025 10:24:32 AM
Yes I agree. Not seeing the ESMO CRC
(3)
Respert24
07/08/2025 10:15:34 AM
Exactly. You'd hope everyone involved
(13)
Riztheinvestor
07/08/2025 10:12:45 AM
Great pasta metaphor. But some of us
(3)
Jake2212
07/08/2025 10:03:46 AM
Respert: And when the FDA stopped LL
(12)
Riztheinvestor
07/08/2025 10:00:14 AM
This is very interesting. Havent
(8)
mountaineer
07/08/2025 9:30:46 AM
Good job! Only 376 words
(8)
Respert24
07/08/2025 8:55:40 AM
Your questions simple enough without
(27)
MGK_2
07/08/2025 7:10:13 AM
I didn't get any responses, so I put
(8)
ohm20
07/08/2025 12:50:27 AM
So I turned to our " friend" A I for
(9)
Shelly2626
07/07/2025 11:48:08 PM
Been here , but in CYDY SINCE
(5)
brentie
07/07/2025 10:43:59 PM
Leronlimab Shows Encouraging Survival
(10)
brentie
07/07/2025 10:28:32 PM
New Trials Target Brain, Bladder,
(7)
My69z
07/07/2025 8:37:28 PM
The FDA ..HAS approved LL @ 700mg CRC
(7)
MidnightRider
07/07/2025 8:07:57 PM
It's obvious I have been struggling
(9)
Mr3Putt
07/07/2025 6:21:49 PM
FWIW on July 9 it'll be the one year
(5)
Shelly2626
07/07/2025 6:18:55 PM
GLTA Longs..... I'm extremely
(10)
chazzledazzle
07/07/2025 5:52:26 PM
Short term newsmakers are Company
(6)
ohm20
07/07/2025 5:50:56 PM
Short version: if a company licenses
(9)
Riztheinvestor
07/07/2025 5:47:18 PM
If I had to guess, and Im not
(17)
KenChowder
07/07/2025 5:18:10 PM
Yes, up nearly 12% on the day --
(6)
hoops
07/07/2025 3:48:32 PM
In the meantime CYDY is quietly up 12%
(4)
nelsonsjavaheads
07/07/2025 3:23:32 PM
Just RELAX. This is a board that we are
(16)
My69z
07/07/2025 2:48:42 PM
Like i said....he was talking 2 someone
cardamine
07/07/2025 2:44:46 PM
poster display session in Hall B0 on
Evil Rabbit
07/07/2025 2:44:31 PM
Because he said he had you on ignore??
(9)
Evil Rabbit
07/07/2025 2:41:27 PM
Language like that will get you blanket
(4)
HouseofCards
07/07/2025 1:27:13 PM
I would expect updates on any or all of
(4)
KenChowder
07/07/2025 12:43:08 PM
Short version: if a company licenses
(1)
Cycl2R
07/07/2025 11:32:45 AM
Jake wrote re LL TNBC conclusive trial:
(3)
MidnightRider
07/07/2025 11:08:42 AM
Can someone please offer an opinion
(1)
Respert24
07/07/2025 10:51:39 AM
I cant see the business model
(21)
Mr3Putt
07/07/2025 10:31:49 AM
Not a pharma rep nor exec so I have no
Evil Rabbit
07/07/2025 10:30:37 AM
The five-year anniversary of our RTF
(14)
My69z
07/07/2025 10:25:16 AM
Or, what do you think about ICI's
My69z
07/07/2025 10:12:07 AM
Cytodyn's not for sale ---- for yrs
(1)
Mr3Putt
07/07/2025 10:05:14 AM
Paying Cytodyn dosen't get them ICI
My69z
07/07/2025 9:59:29 AM
Partnering directly with us, dosen't
(1)
Mr3Putt
07/07/2025 9:46:29 AM
If LL makes all ICI's better, why
(4)
My69z
07/07/2025 9:43:12 AM
Cytodyn should buy the CTC test
My69z
07/07/2025 9:37:44 AM
Why would an ICI mfgr spend let's say
Mr3Putt
07/07/2025 7:22:13 AM
IIRC by July 2nd of this month.
hoops
07/07/2025 5:14:23 AM
Is the $2M payment from Amarex due this
(1)
My69z
07/07/2025 3:27:00 AM
December 7, 2022 R&D Update: Pg. 98
(1)
Newer
Older
Recent Articles
Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
Google's Decision to Shift Women Techmakers Program Sparks Controversy
Podiatry Content Connection Unveils Innovative AI Solutions
zerohash Europe Gets MiCAR Authorization for Crypto Services
Tech Titans' Dinner Sparks Fried Chicken Stock Boom
The Rise of the Silver American Eagle: Why Stackers Are Going All In
Tenaris Launches $600 Million in Share Buyback for Investors
Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
Tenaris Launches $600 Million in Share Buybacks Amid Growth
Exploring AI Adoption Among Small Businesses Across The U.S.
Shiba Inu ETF Filing Sparks Significant Token Burn Event
Investors of Avantor, Inc. Encouraged to Seek Justice Together
Al Salam Bank Commemorates ASB Capital's Successful Year
Tom Lee: The Trusted Face of Ethereum in the Finance World
Elon Musk and Sam Altman: The Roadster Refund Debate
Navigating Career Transitions: Insights from Industry Experts
Key Steps for Fortinet, Inc. Investors Ahead of Class Action
Air Traffic Controllers Face Staffing Crisis Amid Shutdown
Warren Challenges Trump on Rising Costs Affecting Families
James Hardie Industries Investors Invited to Join Critical Lawsuit
Fluor Corporation's Investors Encouraged to Act Now for Justice
Bitcoin Surges to $100K Amidst Market Challenges and Insights
Ziegler Successfully Completes $44M Financing for Frasier
Lowe's Contributes $1 Million for Hurricane Recovery in Jamaica
Celebrate Dodgers' Triumph with New Era's 2025 Collection
Richmond Terrace Capital Launches New €1.5 Billion Investment Fund
Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing
Sequoia Capital Launches $950M Fund to Fuel AI Innovators
Virginia Veterans Celebrate with Free Book Vouchers for Stories
Innovative Advancements of Poain BlockEnergy in Global DeFi Market
Investors of aTyr Pharma Should Secure Legal Help Now
Bahrain Premieres Revolutionary Rooftop Solar Power Initiative
Deqing's Pearl Mussel Award: A Mark of Agricultural Heritage
Buck Sexton Unveils the Dawn of America’s Next Wealth Era
Navigating the Promising Journey of Mutuum Finance and MUTM
Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
Top Stock Insights: Palantir's Surge and Pfizer's Struggles
The Last Messages of Charlie Kirk Revealing His Fears
Significant Stock Declines: Fiserv, eBay, and Garmin Under Pressure
Major Moves in Tech: Earnings Reports & Market Trends Ahead
Ford Faces Major Recall Challenges But Sees Opportunities Ahead
Discover the Hidden Gems: Stocks Gaining Investor Interest
OncoHost Showcases Innovative Insights in NSCLC Proteomics
Mutuum Finance Gears Up for Exciting V1 Launch with $18M Raised
Apple's Impressive Earnings, Bold Future Predictions Unveiled
Fangzhou's Innovative AI Solutions Transform Chronic Care Management
Fangzhou Innovates Chronic Disease Management with AI Solutions
CoorsTek Bioceramics Triumphs in Legal Right to Market Hip Components